These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 39149873
21. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway. Liang W, Liu M, Su Y, Wen Y, Wang L, Shan J, Zhao J, Xie K, Wang J. IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571 [Abstract] [Full Text] [Related]
22. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway. Liao YX, Zhang ZP, Zhao J, Liu JP. Cell Physiol Biochem; 2018 Mar; 48(3):1382-1396. PubMed ID: 30048971 [Abstract] [Full Text] [Related]
23. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4. Jiang H, Su Z, Hu W, Yuan X, Yu T, Yang J, Xiao X, Zheng S, Lin B. OMICS; 2023 May; 27(5):215-226. PubMed ID: 37196148 [Abstract] [Full Text] [Related]
24. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway. Chen W, Kong KK, Xu XK, Chen C, Li H, Wang FY, Peng XF, Zhang Z, Li P, Li JL, Li FC. Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288 [Abstract] [Full Text] [Related]
25. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway. Gao X, Jiang W, Ke Z, Huang Q, Chen L, Zhang G, Li C, Yu X. Biochem Biophys Res Commun; 2022 Jan 01; 586():34-41. PubMed ID: 34826698 [Abstract] [Full Text] [Related]
26. TMEM17 Promotes Tumor Progression in Glioblastoma by Activating the PI3K/AKT Pathway. Wang S, Zhou Q, Yan S, Liu C, Li F, Feng D, He M. Front Biosci (Landmark Ed); 2024 Aug 16; 29(8):285. PubMed ID: 39206901 [Abstract] [Full Text] [Related]
27. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway. Yang G, Su F, Han BX, Su HX, Guo CH, Yu SH, Guan QL, Hou XM. Biochem Pharmacol; 2024 May 16; 223():116133. PubMed ID: 38494066 [Abstract] [Full Text] [Related]
29. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation. Qiu XY, Hu DX, Chen WQ, Chen RQ, Qian SR, Li CY, Li YJ, Xiong XX, Liu D, Pan F, Yu SB, Chen XQ. Biochim Biophys Acta Mol Basis Dis; 2018 May 16; 1864(5 Pt A):1754-1769. PubMed ID: 29510196 [Abstract] [Full Text] [Related]
30. Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival. Xiong Z, Wu S, Li FJ, Luo C, Jin QY, Connolly ID, Hayden Gephart M, You L. Genes (Basel); 2022 Oct 17; 13(10):. PubMed ID: 36292767 [Abstract] [Full Text] [Related]
31. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR, Irani S, Soleimani M, Arefian E, Kouhkan F. J Cell Biochem; 2019 Oct 17; 120(10):16760-16774. PubMed ID: 31243804 [Abstract] [Full Text] [Related]
32. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ, Lin S, Liu JN, Zhang MB, Du YT, Zhang DD, Xu WH, Wang HB. J Cell Physiol; 2019 Aug 17; 234(10):18587-18601. PubMed ID: 30953349 [Abstract] [Full Text] [Related]
33. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway. Mu Q, Wang L, Yu F, Gao H, Lei T, Li P, Liu P, Zheng X, Hu X, Chen Y, Jiang Z, Sayari AJ, Shen J, Huang H. Cancer Biol Ther; 2015 Aug 17; 16(4):623-33. PubMed ID: 25719943 [Abstract] [Full Text] [Related]
34. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mikheev AM, Mikheeva SA, Severs LJ, Funk CC, Huang L, McFaline-Figueroa JL, Schwensen J, Trapnell C, Price ND, Wong S, Rostomily RC. Mol Oncol; 2018 Jun 17; 12(7):1188-1202. PubMed ID: 29754406 [Abstract] [Full Text] [Related]
35. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z. Tissue Cell; 2022 Aug 17; 77():101817. PubMed ID: 35679685 [Abstract] [Full Text] [Related]
36. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling. Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J, Chang Y, Zhang Y, Liang D, Shen D, Zhang G, Meng S, Piao H. Cell Death Dis; 2020 Apr 14; 11(4):230. PubMed ID: 32286266 [Abstract] [Full Text] [Related]
37. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway. Ni H, Wang K, Xie P, Zuo J, Liu W, Liu C. Cell Mol Neurobiol; 2021 Jan 14; 41(1):79-90. PubMed ID: 32236901 [Abstract] [Full Text] [Related]
38. DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation. Ma YS, Wu ZJ, Bai RZ, Dong H, Xie BX, Wu XH, Hang XS, Liu AN, Jiang XH, Wang GR, Jiang JJ, Xu WH, Chen XP, Tan GH, Fu D, Liu JB, Liu Q. Cancer Lett; 2018 Jun 01; 423():86-94. PubMed ID: 29548818 [Abstract] [Full Text] [Related]
39. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways. Li S, Chen X, Mao L, Zahid KR, Wen J, Zhang L, Zhang M, Duan J, Duan J, Yin X, Wang Y, Zhao L, Tang X, Wang X, Xu G. Brain Res; 2018 Aug 01; 1692():154-162. PubMed ID: 29782850 [Abstract] [Full Text] [Related]
40. Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding. Lv D, Jia F, Hou Y, Sang Y, Alvarez AA, Zhang W, Gao WQ, Hu B, Cheng SY, Ge J, Li Y, Feng H. Cancer Res; 2017 Nov 15; 77(22):6190-6201. PubMed ID: 29021135 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]